Trichostatin a prevents neointimal hyperplasia via activation of Krüppel like factor 4

Vascular Pharmacology

Volumn 55, Issue 5-6, 2011, Pages 127-134

  Kee, Hae Jin ^a,b   Kwon, Jin Sook ^b   Shin, Sera ^a,b   Ahn, Youngkeun ^b   Jeong, Myung Ho ^b   Kook, Hyun ^a,b  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Cell cycle regulator; Kr ppel like factor 4; Neointimal hyperplasia; Trichostatin A; Vascular smooth muscle cell

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 4; RECOMBINANT PROTEIN; TRICHOSTATIN A;

ANIMAL; ARTICLE; CAROTID ARTERY DISEASE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE SILENCING; GENETICS; HYPERPLASIA; INTIMA; MALE; METABOLISM; PATHOLOGY; PROMOTER REGION; RAT; SPRAGUE DAWLEY RAT; THORACIC AORTA; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; CAROTID ARTERY DISEASES; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; GENE SILENCING; HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACIDS; HYPERPLASIA; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MUSCLE, SMOOTH, VASCULAR; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TUNICA INTIMA; UP-REGULATION;

MLCS; MLOWN;

EID: 84863556840     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.07.001     Document Type: Article

References (53)

1. Adams, H.P. Jr., Secondary prevention of atherothrombotic events after ischemic stroke. Mayo Clinic Proceedings 84 (2009), 43–51.
2. Berliner, J.A., Navab, M., Fogelman, A.M., Frank, J.S., Demer, L.L., Edwards, P.A., Watson, A.D., Lusis, A.J., Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91 (1995), 2488–2496.
3. Bochaton-Piallat, M.L., Gabbiani, G., Modulation of smooth muscle cell proliferation and migration: role of smooth muscle cell heterogeneity. Handbook of Experimental Pharmacology, 2005, 645–663.
4. Brydon, L., Magid, K., Steptoe, A., Platelets, coronary heart disease, and stress. Brain, Behavior, and Immunity 20 (2006), 113–119.
5. Carew, J.S., Giles, F.J., Nawrocki, S.T., Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Letter 269 (2008), 7–17.
6. Chen, Z.Y., Rex, S., Tseng, C.C., Kruppel-like factor 4 is transactivated by butyrate in colon cancer cells. Journal of Nutrition 134 (2004), 792–798.
7. Choi, H.C., Lee, K.Y., Lee, D.H., Kang, Y.J., Heme oxygenase-1 induced by aprotinin inhibits vascular smooth muscle cell proliferation through cell cycle arrest in hypertensive rats. Korean Journal of Physiology and Pharmacology 13 (2009), 309–313.
8. Clowes, A.W., Reidy, M.A., Clowes, M.M., Mechanisms of stenosis after arterial injury. Laboratory Investigation 49 (1983), 208–215.
9. Dong, C., Goldschmidt-Clermont, P.J., Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease. Journal of Interventional Cardiology 20 (2007), 93–99.
10. Fiaschi-Taesch, N., Sicari, B., Ubriani, K., Cozar-Castellano, I., Takane, K.K., Stewart, A.F., Mutant parathyroid hormone-related protein, devoid of the nuclear localization signal, markedly inhibits arterial smooth muscle cell cycle and neointima formation by coordinate up-regulation of p15Ink4b and p27kip1. Endocrinology 150 (2009), 1429–1439.
11. Freidkin, I., Herman, M., Tobar, A., Chagnac, A., Ori, Y., Korzets, A., Gafter, U., Effects of histone deacetylase inhibitors on rat mesangial cells. American Journal of Physiology. Renal Physiology 298 (2010), F426–F434.
12. Gregoire, S., Xiao, L., Nie, J., Zhang, X., Xu, M., Li, J., Wong, J., Seto, E., Yang, X.J., Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Molecular and Cellular Biology 27 (2007), 1280–1295.
13. Jaster, M., Horstkotte, D., Willich, T., Stellbaum, C., Knie, W., Spencker, S., Pauschinger, M., Schultheiss, H.P., Rauch, U., The amount of fibrinogen-positive platelets predicts the occurrence of in-stent restenosis. Atherosclerosis 197 (2008), 190–196.
14. Kee, H.J., Eom, G.H., Joung, H., Shin, S., Kim, J.R., Cho, Y.K., Choe, N., Sim, B.W., Jo, D., Jeong, M.H., Kim, K.K., Seo, J.S., Kook, H., Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy. Circulation Research 103 (2008), 1259–1269.
15. Kee, H.J., Kook, H., Kruppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. Journal of Molecular and Cellular Cardiology 47 (2009), 770–780.
16. Kim, T.J., Zhang, Y.H., Kim, Y., Lee, C.K., Lee, M.K., Hong, J.T., Yun, Y.P., Effects of apigenin on the serum- and platelet derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells. Planta Medica 68 (2002), 605–609.
17. Kimes, B.W., Brandt, B.L., Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Experimental Cell Research 98 (1976), 349–366.
18. Klingenberg, R., Hansson, G.K., Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. European Heart Journal 30 (2009), 2838–2844.
19. Langer, H.F., Bigalke, B., Seizer, P., Stellos, K., Fateh-Moghadam, S., Gawaz, M., Interaction of platelets and inflammatory endothelium in the development and progression of coronary artery disease. Seminars in Thrombosis and Hemostasis 36 (2010), 131–138.
20. Manderson, J.A., Mosse, P.R., Safstrom, J.A., Young, S.B., Campbell, G.R., Balloon catheter injury to rabbit carotid artery. I. Changes in smooth muscle phenotype. Arteriosclerosis 9 (1989), 289–298.
21. Mathew, O.P., Ranganna, K., Yatsu, F.M., Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells. Biomedicine and Pharmacotherapy 64 (2010), 733–740.
22. McConnell, B.B., Ghaleb, A.M., Nandan, M.O., Yang, V.W., The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 29 (2007), 549–557.
23. McConnell, B.B., Yang, V.W., Mammalian Kruppel-like factors in health and diseases. Physiological Reviews 90 (2010), 1337–1381.
24. Mukherjee, D., Cho, L., Peripheral arterial disease: considerations in risks, diagnosis, and treatment. Journal of the National Medical Association 101 (2009), 999–1008.
25. North, B.J., Marshall, B.L., Borra, M.T., Denu, J.M., Verdin, E., The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Molecular Cell 11 (2003), 437–444.
26. Ohnishi, S., Ohnami, S., Laub, F., Aoki, K., Suzuki, K., Kanai, Y., Haga, K., Asaka, M., Ramirez, F., Yoshida, T., Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochemical and Biophysical Research Communications 308 (2003), 251–256.
27. Okamoto, H., Fujioka, Y., Takahashi, A., Takahashi, T., Taniguchi, T., Ishikawa, Y., Yokoyama, M., Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1). Journal of Atherosclerosis and Thrombosis 13 (2006), 183–191.
28. Orr, A.W., Hastings, N.E., Blackman, B.R., Wamhoff, B.R., Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. Journal of Vascular Research 47 (2010), 168–180.
29. Otterbein, L.E., Zuckerbraun, B.S., Haga, M., Liu, F., Song, R., Usheva, A., Stachulak, C., Bodyak, N., Smith, R.N., Csizmadia, E., Tyagi, S., Akamatsu, Y., Flavell, R.J., Billiar, T.R., Tzeng, E., Bach, F.H., Choi, A.M., Soares, M.P., Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nature Medicine 9 (2003), 183–190.
30. Qiao, W., Chaoshu, T., Hongfang, J., Junbao, D., Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis. Biochemical and Biophysical Research Communications 396 (2010), 182–186.
31. Rao, R.S., Miano, J.M., Olson, E.N., Seidel, C.L., The A10 cell line: a model for neonatal, neointimal, or differentiated vascular smooth muscle cells?. Cardiovascular Research 36 (1997), 118–126.
32. Rowland, B.D., Peeper, D.S., KLF4, p21 and context-dependent opposing forces in cancer. Nature Reviews. Cancer 6 (2006), 11–23.
33. Shields, J.M., Christy, R.J., Yang, V.W., Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. Journal of Biological Chemistry 271 (1996), 20009–20017.
34. Shimizu, Y., Takeuchi, T., Mita, S., Notsu, T., Mizuguchi, K., Kyo, S., Kruppel-like factor 4 mediates anti-proliferative effects of progesterone with G0/G1 arrest in human endometrial epithelial cells. Journal of Endocrinological Investigation 33 (2010), 745–750.
35. Song, S., Kang, S.W., Choi, C., Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1. Cardiovascular Research 85 (2010), 241–249.
36. Sowa, Y., Orita, T., Minamikawa, S., Nakano, K., Mizuno, T., Nomura, H., Sakai, T., Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochemical and Biophysical Research Communications 241 (1997), 142–150.
37. Suzuki, T., Aizawa, K., Matsumura, T., Nagai, R., Vascular implications of the Kruppel-like family of transcription factors. Arteriosclerosis, Thrombosis, and Vascular Biology 25 (2005), 1135–1141.
38. Tardif, J.C., Gregoire, J., L'Allier, P.L., Prevention of restenosis with antioxidants: mechanisms and implications. American Journal of Cardiovascular Drugs 2 (2002), 323–334.
39. Toth, K.F., Knoch, T.A., Wachsmuth, M., Frank-Stohr, M., Stohr, M., Bacher, C.P., Muller, G., Rippe, K., Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin. Journal of Cell Science 117 (2004), 4277–4287.
40. Tuomisto, T.T., Binder, B.R., Yla-Herttuala, S., Genetics, genomics and proteomics in atherosclerosis research. Annals of Medicine 37 (2005), 323–332.
41. Vinereanu, D., Risk factors for atherosclerotic disease: present and future. Herz 31:Suppl. 3 (2006), 5–24.
42. Wassmann, S., Wassmann, K., Jung, A., Velten, M., Knuefermann, P., Petoumenos, V., Becher, U., Werner, C., Mueller, C., Nickenig, G., Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. Journal of Molecular and Cellular Cardiology 43 (2007), 301–307.
43. Wei, D., Kanai, M., Huang, S., Xie, K., Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 27 (2006), 23–31.
44. Wei, D., Kanai, M., Jia, Z., Le, X., Xie, K., Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Research 68 (2008), 4631–4639.
45. Yang, Y., Goldstein, B.G., Chao, H.H., Katz, J.P., KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biology & Therapy 4 (2005), 1216–1221.
46. Yao, Y.L., Yang, W.M., Seto, E., Regulation of transcription factor YY1 by acetylation and deacetylation. Molecular and Cellular Biology 21 (2001), 5979–5991.
47. Yoon, H.S., Yang, V.W., Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage. Journal of Biological Chemistry 279 (2004), 5035–5041.
48. Yoshida, T., Kaestner, K.H., Owens, G.K., Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circulation Research 102 (2008), 1548–1557.
49. Zhang, W., Geiman, D.E., Shields, J.M., Dang, D.T., Mahatan, C.S., Kaestner, K.H., Biggs, J.R., Kraft, A.S., Yang, V.W., The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. Journal of Biological Chemistry 275 (2000), 18391–18398.
50. Zhang, W., Trible, R.P., Zhu, M., Liu, S.K., McGlade, C.J., Samelson, L.E., Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell angigen receptor-mediated signaling. Journal of Biological Chemistry 275 (2000), 23355–23361.
51. Zhang, Y., Li, N., Caron, C., Matthias, G., Hess, D., Khochbin, S., Matthias, P., HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO Journal 22 (2003), 1168–1179.
52. Zheng, B., Han, M., Bernier, M., Zhang, X.H., Meng, F., Miao, S.B., He, M., Zhao, X.M., Wen, J.K., Kruppel-like factor 4 inhibits proliferation by platelet-derived growth factor receptor beta-mediated, not by retinoic acid receptor alpha-mediated, phosphatidylinositol 3-kinase and ERK signaling in vascular smooth muscle cells. Journal of Biological Chemistry 284 (2009), 22773–22785.
53. Zhu, P., Chen, J.M., Chen, S.Z., Zhang, C., Zheng, S.Y., Long, G., Chen, J., Zhou, Z.L., Fan, R.X., Fan, X.P., Chen, Y.F., Zhuang, J., Matrine inhibits vascular smooth muscle cell proliferation by modulating the expression of cell cycle regulatory genes. Acta Pharmacologica Sinica 31 (2010), 1329–1335.